$CLVS News Article - Journal of Clinical Oncology Publishes Additional Data from Clovis Oncology's TRITON2 Clinical Trial Evaluating Rubraca (rucaparib) for the Treatment of mCRPC in Patients with BRCA1/2 Gene Mutations
https://marketwirenews.com/news-releases/jour...60729.html